Overview
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 5, 2025 | Algernon NeuroScience Appoints Validcare as CRO for its Phase 2a DMT Human Stroke Trial and Announces Validcare’s USD $170K Equity Investment | VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleas... |
| Jan 8, 2024 | TECLens Chooses Validcare as CRO for its Presbyopia Study | Validcare’s approach is tailored to meet the regulatory and budgetary needs of small biotech. Validcare’s approach to data collection and data management provides us the flexibility that is critical to us in this early stage of development.... |
| Jan 5, 2024 | Validcare Selected by Emerging Biotech, Coologics, to Lead Women’s Health Study | Validcare’s CRO approach provides Coologics unmatched confidence, visibility and control to complete its study on time, on budget, and with high data integrity. I trust Validcare’s experience in women’s health and their end-to-end approach ... |
| Apr 15, 2021 | Validcare Announces a Second Cohort of CBD Brands Joins Safety Study to Gather Data for FDA | "We are excited to have our state of the art, decentralized trial technology overcome the hurdles of performing research during a pandemic." DENVER (PRWEB) April 15, 2021 Validcare announced today the addition of a second cohort o... |
| Mar 23, 2021 | Validcare’s Clinical Study Reports Preliminary Results of CBD Liver Safety | Our primary endpoint in this study is to observe potential liver effects in adults ingesting oral forms of hemp derived CBD for a minimum of 60 days. What we observed to date is no clinical evidence of liver disease in any participants. DEN... |
| Mar 16, 2021 | ValidCare joins Council for Responsible Nutrition to Help Support and Advance Scientific Research | Our objective is to help companies deliver the safest and most effective products to market, integrating science and real-world evidence to support health and wellness claims. DENVER (PRWEB) March 16, 2021 ValidCare, a leading provider of d... |
Reviews 0
FAQ about Validcare
When was Validcare founded?
Validcare was founded in 2014.
What has the press written about Validcare?
Parsers VC has collected 7 articles mentioning Validcare, among them “Algernon NeuroScience Appoints Validcare as CRO for its Phase 2a DMT Human Stroke Trial and Announces Validcare’s USD $170K Equity Investment” (Feb 5, 2025) and “TECLens Chooses Validcare as CRO for its Presbyopia Study” (Jan 8, 2024).
Is Validcare still active?
Yes, Validcare is active; its latest activity on Parsers VC dates from Nov 3, 2026.